Taban Mehryar, Singh Rishi P, Chung Jeffrey Yau-Huei, Lowder Careen Y, Perez Victor L, Kaiser Peter K
Cole Eye Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Am J Ophthalmol. 2007 Jul;144(1):50-54. doi: 10.1016/j.ajo.2007.03.051.
To report an association between uveitis and sterile endophthalmitis after intravitreal triamcinolone acetonide injection.
Retrospective case series.
A retrospective analysis of all patients receiving intravitreal triamcinolone injection at the Cole Eye Institute from January 2006 through September 2006 was carried out to evaluate for the occurrence of bacterial or sterile endophthalmitis. Indication for treatment, ocular history, best-corrected Snellen visual acuity, and clinical examination findings were recorded from the clinical charts before injection and at last follow-up.
A total of 310 eyes received intravitreal triamcinolone injection for various causes, including age-related macular degeneration (AMD), diabetic retinopathy, vascular occlusion, and cystoid macular edema (CME) resulting from uveitis. There were no cases of culture-positive infectious endophthalmitis. There were six cases (1.9%) of sterile endophthalmitis. Of these six cases, four had prior history of uveitis, whereas only 20 of the 310 cases had a prior history of uveitis. All six patients sought treatment within three days of injection, and all recovered rapidly. Presenting visual acuity was either counting fingers or hand movements. Median best-corrected visual acuity before injection was 20/100(+), whereas median final visual acuity was 20/80(-).
Patients with a history of uveitis may be at increased risk of experiencing sterile endophthalmitis resulting from intravitreal triamcinolone injection.
报告玻璃体内注射曲安奈德后葡萄膜炎与无菌性眼内炎之间的关联。
回顾性病例系列研究。
对2006年1月至2006年9月在科尔眼科研究所接受玻璃体内曲安奈德注射的所有患者进行回顾性分析,以评估细菌性或无菌性眼内炎的发生情况。从注射前及最后一次随访时的临床病历中记录治疗指征、眼部病史、最佳矫正视力及临床检查结果。
共有310只眼因各种原因接受了玻璃体内曲安奈德注射,包括年龄相关性黄斑变性(AMD)、糖尿病性视网膜病变、血管阻塞以及葡萄膜炎导致的黄斑囊样水肿(CME)。无培养阳性的感染性眼内炎病例。有6例(1.9%)无菌性眼内炎。在这6例中,4例有葡萄膜炎病史,而310例中仅有20例有葡萄膜炎病史。所有6例患者在注射后三天内寻求治疗,且均迅速康复。就诊时视力为指数或手动。注射前最佳矫正视力中位数为20/100(+),而最终视力中位数为20/80(-)。
有葡萄膜炎病史的患者可能因玻璃体内注射曲安奈德而发生无菌性眼内炎的风险增加。